Equities

Anhui Huaheng Biotechnology Co Ltd

688639:SHH

Anhui Huaheng Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)27.47
  • Today's Change-7.44 / -21.31%
  • Shares traded2.53m
  • 1 Year change-64.39%
  • Beta1.5580
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Anhui Huaheng Biotechnology Co Ltd is a China-based company specializing in the research and development, production and sales of amino acids and other bio-based products based on alanine series products. The Company is an enterprise focusing on synthetic biotechnology and mainly engaged in the research and development, production and sales of amino acid and its derivative products. The Company's main products include alanine series products (L-alanine, DL-alanine, β-alanine), calcium D-pantothenate and α-arbutin. The Company's products are mainly used in intermediates, animal nutrition, daily chemical care, functional food and nutrition, plant nutrition and other fields. The Company distributes its products and services within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)2.11bn
  • Net income in CNY299.01m
  • Incorporated2005
  • Employees1.69k
  • Location
    Anhui Huaheng Biotechnology Co LtdNo. 197 Chang'an Road, Gaoxin DistrictHEFEI 231031ChinaCHN
  • Phone+86 55 165689046
  • Fax+86 55 165689468
  • Websitehttp://www.huahengbio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Sanyuan Foods Co Ltd7.09bn115.10m6.60bn6.21k57.171.29--0.93050.07640.07644.713.390.7667.668.281,140,594.001.431.082.041.7222.6325.961.871.880.6985--0.291628.31-1.381.01502.396.120.78035.78
Namchow Food Group Shanghai Co Ltd3.10bn257.50m7.43bn1.71k28.952.18--2.400.60460.60467.298.020.74514.5716.731,815,694.006.208.147.5910.7524.3830.018.3210.282.46--0.100622.847.735.4544.73-3.4811.63--
Shanghai Ziyan Foods Co Ltd3.42bn339.05m7.46bn2.00k21.953.74--2.180.82090.82098.294.821.0714.5021.631,711,192.0011.08--15.72--23.02--10.33--1.58--0.2087---1.46--49.46------
Lotus Holdings Co Ltd2.42bn200.47m8.70bn1.36k44.455.08--3.590.10910.10911.300.95560.845814.9618.521,786,674.007.033.1210.597.5921.9214.308.313.631.57--0.45170.0024.233.97181.43--84.81--
Anhui Huaheng Biotechnology Co Ltd2.11bn299.01m8.72bn1.69k26.844.29--4.131.301.309.198.130.56255.649.831,249,640.007.8616.7412.6422.4130.2939.2113.9722.340.431614.070.524125.2036.6335.7240.3242.8482.09--
Jiangsu Hengshun Vinegar Industry Co Ltd2.00bn68.82m8.95bn2.07k130.142.69--4.480.0620.0621.813.000.49285.9438.00967,447.401.566.171.827.9134.3637.993.169.792.659.010.000661.65-1.524.33-37.03-22.3122.49-5.68
Guangzhou Restaurant Group Co Ltd5.13bn506.88m9.10bn5.77k17.952.37--1.770.89110.89119.016.740.688510.3514.88888,057.607.2611.5211.6215.9632.2239.4010.5413.170.9489--0.259140.7519.1714.075.217.473.7310.93
Shanghai Milkground Food Tech Co Ltd4.57bn114.60m9.25bn2.56k80.352.11--2.020.22480.22488.968.550.61885.3938.901,787,234.001.552.212.173.2827.4934.072.513.011.4711.060.36830.00-16.1627.00-53.9042.9218.61--
Snowsky Salt Industry Group Co Ltd6.00bn546.49m9.73bn5.68k18.051.27--1.620.32520.32523.594.630.536811.1829.781,055,958.004.956.676.859.3326.6430.559.2310.421.45--0.088647.76-2.7722.15-7.8637.8521.3133.59
Toly Bread Co Ltd6.34bn549.79m10.11bn10.06k18.392.00--1.590.34370.34373.963.150.899828.8612.31630,077.407.8012.229.6714.3921.8828.138.6711.290.541435.610.2077.051.086.94-10.29-2.2216.82-9.93
Data as of Sep 13 2024. Currency figures normalised to Anhui Huaheng Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

23.63%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 30 Sep 202415.92m6.97%
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 202412.22m5.35%
Bosera Asset Management Co., Ltd.as of 30 Jun 20248.79m3.85%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20243.05m1.34%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20243.05m1.34%
Industrial Securities Investment Management Co. Ltd.as of 31 Dec 20232.84m1.24%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20242.53m1.11%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 20242.37m1.04%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20241.68m0.74%
CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 20241.50m0.66%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.